Fig. 1
Flowchart of the trial profile. HCC, hepatocellular carcinoma; DEB-TACE, drug-eluting beads trans-arterial chemoembolization; cTACE, conventional trans-arterial chemoembolization; 5-Fu, 5-Fluorouracil.
Fig. 1 | Scientific Reports
Flowchart of the trial profile. HCC, hepatocellular carcinoma; DEB-TACE, drug-eluting beads trans-arterial chemoembolization; cTACE, conventional trans-arterial chemoembolization; 5-Fu, 5-Fluorouracil.
